Mn Services Vermogensbeheer B.V. Has $12.67 Million Stock Holdings in GE HealthCare Technologies Inc. $GEHC

Key Points

• Mn Services Vermogensbeheer B.V. increased its stake in GE HealthCare Technologies by 15.5%, owning a total of 171,100 shares valued at approximately $12.67 million.
• Several institutional investors, including JPMorgan Chase & Co., also significantly boosted their investments, with JPMorgan increasing its stake by 49.9% in the first quarter.
• GE HealthCare Technologies reported strong quarterly earnings of $1.06 per share, exceeding analyst expectations, and set fiscal year 2025 EPS guidance between 4.430 and 4.630.

Mn Services Vermogensbeheer B.V. increased its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC - Free Report) by 15.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 171,100 shares of the company's stock after acquiring an additional 22,900 shares during the quarter. Mn Services Vermogensbeheer B.V.'s holdings in GE HealthCare Technologies were worth $12,673,000 at the end of the most recent quarter.

Several other hedge funds have also recently added to or reduced their stakes in the stock. Glenview Trust co lifted its stake in GE HealthCare Technologies by 4.4% in the first quarter. Glenview Trust co now owns 3,294 shares of the company's stock valued at $266,000 after buying an additional 139 shares during the period. Knuff & Co LLC increased its holdings in shares of GE HealthCare Technologies by 1.5% in the first quarter. Knuff & Co LLC now owns 10,276 shares of the company's stock worth $829,000 after acquiring an additional 150 shares in the last quarter. Graypoint LLC increased its holdings in shares of GE HealthCare Technologies by 5.7% in the first quarter. Graypoint LLC now owns 3,028 shares of the company's stock worth $244,000 after acquiring an additional 162 shares in the last quarter. Ferguson Wellman Capital Management Inc. increased its holdings in shares of GE HealthCare Technologies by 3.2% in the first quarter. Ferguson Wellman Capital Management Inc. now owns 5,336 shares of the company's stock worth $431,000 after acquiring an additional 166 shares in the last quarter. Finally, Spire Wealth Management increased its holdings in shares of GE HealthCare Technologies by 5.2% in the first quarter. Spire Wealth Management now owns 3,367 shares of the company's stock worth $272,000 after acquiring an additional 166 shares in the last quarter. Institutional investors and hedge funds own 82.06% of the company's stock.

Analyst Upgrades and Downgrades

GEHC has been the subject of a number of research reports. Wall Street Zen upgraded GE HealthCare Technologies from a "hold" rating to a "buy" rating in a report on Saturday, May 31st. Citigroup raised their price target on GE HealthCare Technologies from $89.00 to $93.00 and gave the company a "buy" rating in a research note on Thursday, July 31st. BTIG Research restated a "buy" rating on shares of GE HealthCare Technologies in a research note on Monday, July 14th. Zacks Research upgraded GE HealthCare Technologies from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 28th. Finally, Morgan Stanley set a $74.00 price target on GE HealthCare Technologies in a research note on Thursday. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat, GE HealthCare Technologies presently has an average rating of "Moderate Buy" and an average target price of $88.40.

GE HealthCare Technologies Stock Performance

Shares of GEHC traded up $0.91 during mid-day trading on Friday, reaching $74.91. The company's stock had a trading volume of 6,294,083 shares, compared to its average volume of 3,137,968. GE HealthCare Technologies Inc. has a 1-year low of $57.65 and a 1-year high of $94.80. The stock has a market cap of $34.20 billion, a P/E ratio of 15.35, a PEG ratio of 2.83 and a beta of 1.13. The business has a 50-day simple moving average of $74.53 and a two-hundred day simple moving average of $73.27. The company has a current ratio of 1.16, a quick ratio of 0.93 and a debt-to-equity ratio of 0.85.

GE HealthCare Technologies (NASDAQ:GEHC - Get Free Report) last released its quarterly earnings data on Wednesday, July 30th. The company reported $1.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.91 by $0.15. GE HealthCare Technologies had a return on equity of 23.93% and a net margin of 11.22%.The company had revenue of $5 billion during the quarter, compared to analysts' expectations of $4.96 billion. During the same period last year, the firm posted $1.00 earnings per share. The business's revenue was up 3.5% on a year-over-year basis. GE HealthCare Technologies has set its FY 2025 guidance at 4.430-4.630 EPS. As a group, equities research analysts anticipate that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 25th were issued a dividend of $0.035 per share. This represents a $0.14 annualized dividend and a yield of 0.2%. The ex-dividend date of this dividend was Friday, July 25th. GE HealthCare Technologies's dividend payout ratio (DPR) is presently 2.87%.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.